Clinical Trials Directory

Trials / Unknown

UnknownNCT06313385

Investigating the Impact of Indocyanine Green Titration on Fluorescent Intensity in Free Flap : An Exploration of Alternative Indicators

The Effect of Indocyanine Green Titration on Fluorescent Intensity Degree in Free Flap : A Lookout to Flap Surface Temperature, TCPO2, TCPCO2, HIF-1 Alpha Expression Level, and Histopathology

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
63 (estimated)
Sponsor
Indonesia University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study is a randomized clinical trials that aim to determine the effect of Indocyanine Green (ICG) titration dose on the intensity degree of ICG fluorescence imaging results. In addition, this study will also determine the relationship of other indicators such as flap surface temperature, transcutaneous pressure of carbon dioxide (TcPCO2), transcutaneous pressure of oxygen (TcPCO2), HIF - 1 alpha expression, and flap histopathology morphology to the intensity degree of ICG fluorescence imaging results with titrated doses.

Detailed description

The ICG contrast solution will be evaluated with Near-Infrared (NIR) camera that being fixated 20 cm above the flap after the injection. The imaging result will be analyzed using ImageJ Application to assess the grey value. The fluorescent intensity of ICG will be compared with other tests. Drop Out Criteria : * Patients who are unable to complete the research procedure due to various condition, such as death * Patients who experience complications or worsening, during and after surgery.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTIndocyanine Green Fluorescence (ICG)The ICG will be injected intravenously and being assessed with Near-infrared (NIR) camera FLUORO4000XL 20 cm above the flap and fluorescence intensity counted with application called ImageJ
DIAGNOSTIC_TESTTemperaturePortable thermal imaging camera called Forward-looking infrared (FLIR) ONE® was used to assess flap and normal skin temperature. The FLIR ONE® device was place in perpendicular manner from the skin. The images were attained in two points of times which is direct temperature and after cold challenge test.
DIAGNOSTIC_TESTTranscutaneous oxygen and carbon dioxide pressureThe partial transcutaneous pressure is measured in flap using transcutaneous monitor (TCM) Combi probe. The probe should be cleaned using alcohol pads before use. After 5-10 minutes, the TCM 4 machine monitor should show stable transcutaneous oxygen and carbon dioxide pressure from the flap
DIAGNOSTIC_TESTHistopathologyA part of tissue from free flap is acquired and stored in 10% formalin tube. Later on, the tissue was colored with hematoxylin-eosin, neutrophile count, necrosis volume, and vessel proliferation will be assessed
DIAGNOSTIC_TESTHypoxia inducible factor-1 (HIF-1) alphaPeripheral tissue from distal free flap (0,5 x 0,5 cm in size) is obtained and stored in tube with dry ice. The tissue is assessed with human HIF - 1 Alpha Enzyme-Linked Immunosorbent Assay (ELISA) kit ab171577.

Timeline

Start date
2023-01-01
Primary completion
2024-03-29
Completion
2024-03-29
First posted
2024-03-15
Last updated
2024-03-15

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT06313385. Inclusion in this directory is not an endorsement.